NCT03727074View on ClinicalTrials.gov

Bioequivalence Study to Compare Sol-Gel Technologies' 5-FU Cream With Efudex® (5-FU) Cream

PHASE3CompletedINTERVENTIONAL
Enrollment

462

Participants

Timeline

Start Date

December 21, 2018

Primary Completion Date

December 19, 2019

Study Completion Date

December 19, 2019

Conditions
Actinic Keratosis (AK)
Interventions
DRUG

5-FU Cream

topical cream twice a day

DRUG

Efudex®

topical cream twice a day

DRUG

Vehicle

topical cream twice a day

Trial Locations (1)

90703

Core Healthcare Group, Cerritos

All Listed Sponsors
lead

Sol-Gel Technologies, Ltd.

INDUSTRY

NCT03727074 - Bioequivalence Study to Compare Sol-Gel Technologies' 5-FU Cream With Efudex® (5-FU) Cream | Biotech Hunter | Biotech Hunter